Arrowhead Pharmaceuticals (ARWR) Equity Income (2010 - 2026)
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Equity Income (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Arrowhead Pharmaceuticals | 12.35 Bn | 10.75 Bn | - | -2.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.47 Mn |
| Mar 31, 2026 | -6.72 Mn |
| Sep 30, 2014 | -9,524.00 |
| Jun 30, 2014 | 78,702.00 |
| Mar 31, 2014 | -9,597.00 |
| Dec 31, 2013 | -138,456.00 |
| Sep 30, 2013 | -260,442.00 |
| Jun 30, 2013 | -159,530.00 |
| Mar 31, 2013 | -157,612.00 |
| Dec 31, 2012 | -63,557.00 |
| Sep 30, 2012 | -34,793.00 |
| Jun 30, 2012 | -34,573.00 |
| Mar 31, 2012 | -64,261.00 |
| Dec 31, 2011 | -106,527.00 |
| Sep 30, 2011 | -66,813.00 |
| Jun 30, 2011 | -70,366.00 |
| Mar 31, 2011 | -74,827.00 |
| Dec 31, 2010 | 48,826.00 |
| Sep 30, 2010 | -53,813.00 |
| Jun 30, 2010 | -66,489.00 |